Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

CDRH Unveils Its Collaborative Matrix Organization To Help Safety Reviews

This article was originally published in The Gray Sheet

Executive Summary

FDA's device center has identified 13 collaborative product groups - or "matrix groups" - that will begin functioning in January to enhance its ability to make use of postmarket safety information

You may also be interested in...



Cross-Center CDRH Matrix Goes Live After Six Months Of Ground Work

Recently appointed leaders of CDRH's new cross-center post-market safety "matrix" organization are officially on the job, beginning July 14, after six months of initial training and testing of the collaborative system

Cross-Center CDRH Matrix Goes Live After Six Months Of Ground Work

Recently appointed leaders of CDRH's new cross-center post-market safety "matrix" organization are officially on the job, beginning July 14, after six months of initial training and testing of the collaborative system

Moves At FDA: Nguyen Tapped For Combo Office, St. Pierre Returns To OIVD

FDA has recently made several key personnel changes in areas impacting device regulation

Related Content

Latest Headlines
See All
UsernamePublicRestriction

Register

MT025488

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel